The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Mylan; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; MSD Oncology (Inst); Mylan; Pfizer; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.
 
Francois Clement Bidard
Consulting or Advisory Role - Archer; Lilly; Novartis; Pfizer; Radius Health
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Freenome (Inst); Menarini Silicon Biosystems (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst)
Patents, Royalties, Other Intellectual Property - patents pending regarding ctDNA detection techniques (Inst)
Travel, Accommodations, Expenses - Amgen; Chugai Pharma; Menarini Silicon Biosystems; Novartis; Pfizer; Roche
 
Celine Callens
No Relationships to Disclose
 
Florence Dalenc
No Relationships to Disclose
 
Barbara Pistilli
Consulting or Advisory Role - Myriad Genetics; Novartis; Pierre Fabre; Puma Biotechnology
Research Funding - Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Novartis; Pfizer
 
Thibault De La Motte Rouge
No Relationships to Disclose
 
Florian Clatot
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Lilly; Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; Roche
 
Veronique D'hondt
No Relationships to Disclose
 
Luis Teixeira
No Relationships to Disclose
 
Helene Vegas
No Relationships to Disclose
 
Sibille Everhard
No Relationships to Disclose
 
Jerome Lemonnier
No Relationships to Disclose
 
Ivan Bieche
No Relationships to Disclose
 
Anne Pradines
No Relationships to Disclose
 
Jean FranCois Paitel
Travel, Accommodations, Expenses - Pfizer
 
Dominique Spaeth
No Relationships to Disclose
 
Isabelle Moullet
No Relationships to Disclose
 
Jean-Yves Pierga
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genomic Health; Illumina; Ipsen; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Roche/Genentech (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
Frederique Berger
No Relationships to Disclose
 
Anne-Claire Hardy-Bessard
No Relationships to Disclose
 
Thomas Bachelot
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; pfizer; Roche